{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:57:47Z","timestamp":1784775467954,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pediatric spinal fusion may be associated with significant intraoperative blood loss, leading to complications from transfusion, hypoperfusion and coagulopathy. One emerging strategy to mediate these risks is by utilization of the anti-fibrinolytic agent tranexamic acid (TXA). However, concerns regarding potential adverse reactions, specifically postoperative seizures and thrombotic events, still exist. To assess these risks, we examined the perioperative morbidity of TXA use in a large national database.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective data from pediatric patients (age 18\u00a0years or younger), discharged between January 2013 to December 2015, who underwent primary or revision posterior spinal fusions, was collected from the Premier Perspective database (Premier, Charlotte, NC). Patients were stratified by TXA use and records were assessed for complications of new onset seizures, strokes, pulmonary embolisms (PE) or deep vein thromboses (DVT) occurring during the perioperative period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this cohort of 2,633 pediatric patients undergoing posterior spinal fusions, most often to treat adolescent idiopathic scoliosis, 15% received TXA. Overall, adverse events were rare in this patient population. The incidence of seizure, stoke, PE, or DVT in the control group was 0.54% (95% CI, 0.31% to 0.94%) and not significantly different from the TXA group. There was no significant difference in the incidence of DVTs, and no incidences of stroke in either group. There were no new-onset seizures or PEs in patients who received TXA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The use of TXA was not associated with an increased risk of adverse events including seizure, stroke, PE, and DVT. Our findings support the safety of TXA use in pediatric patients undergoing spinal fusion surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-022-05604-2","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T04:02:41Z","timestamp":1657252961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of the safety of tranexamic acid use in pediatric patients undergoing spinal fusion surgery: a retrospective comparative cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Iryna","family":"Ivasyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinaba","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Geiselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sariah","family":"Khormaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"7","key":"5604_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.5435\/JAAOS-D-16-00035","volume":"25","author":"ME Oetgen","year":"2017","unstructured":"Oetgen ME, Litrenta J. Perioperative Blood Management in Pediatric Spine Surgery: J Am Acad Orthop Surg. 2017;25(7):480\u20138. https:\/\/doi.org\/10.5435\/JAAOS-D-16-00035.","journal-title":"Perioperative Blood Management in Pediatric Spine Surgery: J Am Acad Orthop Surg"},{"issue":"4","key":"5604_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jspd.2018.01.001","volume":"6","author":"ND Fletcher","year":"2018","unstructured":"Fletcher ND, Marks MC, Asghar JK, Hwang SW, Sponseller PD, Newton PO. Development of Consensus Based Best Practice Guidelines for Perioperative Management of Blood Loss in Patients Undergoing Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis*. Spine Deform. 2018;6(4):424\u20139. https:\/\/doi.org\/10.1016\/j.jspd.2018.01.001.","journal-title":"Spine Deform"},{"issue":"1","key":"5604_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0304-4165(81)90312-3","volume":"673","author":"M Hoylaerts","year":"1981","unstructured":"Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta. 1981;673(1):75\u201385.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"5604_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","volume":"57","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL. Tranexamic Acid: A Review of its Use in Surgery and Other Indications. Drugs. 1999;57(6):1005\u201332. https:\/\/doi.org\/10.2165\/00003495-199957060-00017.","journal-title":"Drugs"},{"issue":"10","key":"5604_CR5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/bjs.9193","volume":"100","author":"K Ker","year":"2013","unstructured":"Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 2013;100(10):1271\u20139. https:\/\/doi.org\/10.1002\/bjs.9193.","journal-title":"Br J Surg"},{"issue":"5","key":"5604_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/pan.13533","volume":"29","author":"D Faraoni","year":"2019","unstructured":"Faraoni D, Rahe C, Cybulski KA. Use of antifibrinolytics in pediatric cardiac surgery: Where are we now? Pediatr Anesth. 2019;29(5):435\u201340. https:\/\/doi.org\/10.1111\/pan.13533.","journal-title":"Pediatr Anesth"},{"issue":"4","key":"5604_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF03009046","volume":"39","author":"JF Hardy","year":"1992","unstructured":"Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth J Can Anesth. 1992;39(4):353\u201365. https:\/\/doi.org\/10.1007\/BF03009046.","journal-title":"Can J Anaesth J Can Anesth"},{"issue":"12","key":"5604_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00045391-199612000-00007","volume":"3","author":"RW Barrons","year":"1996","unstructured":"Barrons RW, Jahr JS. A REVIEW OF POST-CARDIOPULMONARY BYPASS BLEEDING, AMINOCAPROIC ACID, TRANEXAMIC ACID, AND APROTININ. Am J Ther. 1996;3(12):821\u201338. https:\/\/doi.org\/10.1097\/00045391-199612000-00007.","journal-title":"Am J Ther"},{"issue":"1","key":"5604_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.arth.2019.08.015","volume":"35","author":"SB Porter","year":"2020","unstructured":"Porter SB, White LJ, Osagiede O, Robards CB, Spaulding AC. Tranexamic Acid Administration Is Not Associated With an Increase in Complications in High-Risk Patients Undergoing Primary Total Knee or Total Hip Arthroplasty: A Retrospective Case-Control Study of 38,220 Patients. J Arthroplasty. 2020;35(1):45-51.e3. https:\/\/doi.org\/10.1016\/j.arth.2019.08.015.","journal-title":"J Arthroplasty"},{"issue":"10","key":"5604_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1034\/j.1399-6576.2002.461007.x","volume":"46","author":"M Veien","year":"2002","unstructured":"Veien M, S\u00f8rensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand. 2002;46(10):1206\u201311. https:\/\/doi.org\/10.1034\/j.1399-6576.2002.461007.x.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"5604_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jss.2013.08.020","volume":"186","author":"F Huang","year":"2014","unstructured":"Huang F, Wu D, Ma G, Yin Z, Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res. 2014;186(1):318\u201327. https:\/\/doi.org\/10.1016\/j.jss.2013.08.020.","journal-title":"J Surg Res"},{"issue":"3","key":"5604_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00264-013-1787-7","volume":"37","author":"T Iwai","year":"2013","unstructured":"Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop. 2013;37(3):441\u20135. https:\/\/doi.org\/10.1007\/s00264-013-1787-7.","journal-title":"Int Orthop"},{"issue":"4","key":"5604_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jse.2015.09.014","volume":"25","author":"RJ Friedman","year":"2016","unstructured":"Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B. Tranexamic acid decreases blood loss after total shoulder arthroplasty. J Shoulder Elbow Surg. 2016;25(4):614\u20138. https:\/\/doi.org\/10.1016\/j.jse.2015.09.014.","journal-title":"J Shoulder Elbow Surg"},{"issue":"20","key":"5604_CR14","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1097\/BRS.0b013e31814cf139","volume":"32","author":"F Shapiro","year":"2007","unstructured":"Shapiro F, Zurakowski D, Sethna NF. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis. Spine. 2007;32(20):2278\u201383. https:\/\/doi.org\/10.1097\/BRS.0b013e31814cf139.","journal-title":"Spine"},{"issue":"7","key":"5604_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024678","volume":"100","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Xi C, Xu W, Yan J. Role of tranexamic acid in blood loss control and blood transfusion management of patients undergoing multilevel spine surgery: A meta-analysis. Medicine (Baltimore). 2021;100(7): e24678. https:\/\/doi.org\/10.1097\/MD.0000000000024678.","journal-title":"Medicine (Baltimore)"},{"key":"5604_CR16","unstructured":"Lonner BS, Ren Y, Asghar J, Shah SA, Samdani AF, Newton PO. Antifibrinolytic Therapy in Surgery for Adolescent Idiopathic Scoliosis Does the Level 1 Evidence Translate to Practice? Bull Hosp Jt Dis 2013. 2018;76(3):165\u2013170."},{"issue":"8","key":"5604_CR17","doi-asserted-by":"publisher","first-page":"E460","DOI":"10.1097\/BSD.0b013e3182a22a54","volume":"28","author":"LM McLeod","year":"2015","unstructured":"McLeod LM, French B, Flynn JM, Dormans JP, Keren R. Antifibrinolytic Use and Blood Transfusions in Pediatric Scoliosis Surgeries Performed at US Children\u2019s Hospitals. J Spinal Disord Tech. 2015;28(8):E460\u20136. https:\/\/doi.org\/10.1097\/BSD.0b013e3182a22a54.","journal-title":"J Spinal Disord Tech"},{"issue":"22","key":"5604_CR18","doi-asserted-by":"publisher","first-page":"E1170","DOI":"10.1097\/BRS.0000000000004076","volume":"46","author":"MS Hasan","year":"2021","unstructured":"Hasan MS, Yunus SN, Ng CC, Chan CYW, Chiu CK, Kwan MK. Tranexamic Acid in Pediatric Scoliosis Surgery: A Prospective Randomized Trial Comparing High-dose and Low-dose Tranexamic Acid in Adolescent Idiopathic Scoliosis Undergoing Posterior Spinal Fusion Surgery. Spine. 2021;46(22):E1170\u20137. https:\/\/doi.org\/10.1097\/BRS.0000000000004076.","journal-title":"Spine"},{"issue":"2","key":"5604_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.spinee.2020.10.011","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Wang LN, Yang X, et al. The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial. Spine J. 2021;21(2):312\u201320. https:\/\/doi.org\/10.1016\/j.spinee.2020.10.011.","journal-title":"Spine J"},{"issue":"4","key":"5604_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/00000542-200504000-00006","volume":"102","author":"NF Sethna","year":"2005","unstructured":"Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102(4):727\u201332. https:\/\/doi.org\/10.1097\/00000542-200504000-00006.","journal-title":"Anesthesiology"},{"issue":"1","key":"5604_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1186\/s12891-021-04562-5","volume":"22","author":"Y Dong","year":"2021","unstructured":"Dong Y, Liang J, Tong B, Shen J, Zhao H, Li Q. Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial. BMC Musculoskelet Disord. 2021;22(1):663. https:\/\/doi.org\/10.1186\/s12891-021-04562-5.","journal-title":"BMC Musculoskelet Disord"},{"key":"5604_CR22","doi-asserted-by":"publisher","unstructured":"Sui W yuan, Ye F, Yang J lin. Efficacy of tranexamic acid in reducing allogeneic blood products in adolescent idiopathic scoliosis surgery. BMC Musculoskelet Disord. 2016;17(1):187. doi:https:\/\/doi.org\/10.1186\/s12891-016-1006-y","DOI":"10.1186\/s12891-016-1006-y"},{"issue":"23","key":"5604_CR23","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.2106\/JBJS.18.00314","volume":"100","author":"SM Goobie","year":"2018","unstructured":"Goobie SM, Zurakowski D, Glotzbecker MP, et al. Tranexamic Acid Is Efficacious at Decreasing the Rate of Blood Loss in Adolescent Scoliosis Surgery: A Randomized Placebo-Controlled Trial. J Bone Joint Surg Am. 2018;100(23):2024\u201332. https:\/\/doi.org\/10.2106\/JBJS.18.00314.","journal-title":"J Bone Joint Surg Am"},{"key":"5604_CR24","doi-asserted-by":"publisher","unstructured":"Yagi M, Hasegawa J, Nagoshi N, et al. Does the Intraoperative Tranexamic Acid Decrease Operative Blood Loss During Posterior Spinal Fusion for Treatment of Adolescent Idiopathic Scoliosis?: Spine. 2012;37(21):E1336-E1342. doi:https:\/\/doi.org\/10.1097\/BRS.0b013e318266b6e5","DOI":"10.1097\/BRS.0b013e318266b6e5"},{"issue":"5","key":"5604_CR25","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s43390-021-00337-z","volume":"9","author":"S George","year":"2021","unstructured":"George S, Ramchandran S, Mihas A, George K, Mansour A, Errico T. Topical tranexemic acid reduces intra-operative blood loss and transfusion requirements in spinal deformity correction in patients with adolescent idiopathic scoliosis. Spine Deform. 2021;9(5):1387\u201393. https:\/\/doi.org\/10.1007\/s43390-021-00337-z.","journal-title":"Spine Deform"},{"issue":"1","key":"5604_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/ALN.0000000000001665","volume":"127","author":"I Lecker","year":"2017","unstructured":"Lecker I, Wang DS, Kaneshwaran K, Mazer CD, Orser BA. High Concentrations of Tranexamic Acid Inhibit Ionotropic Glutamate Receptors. Anesthesiology. 2017;127(1):89\u201397. https:\/\/doi.org\/10.1097\/ALN.0000000000001665.","journal-title":"Anesthesiology"},{"issue":"12","key":"5604_CR27","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1172\/JCI63375","volume":"122","author":"I Lecker","year":"2012","unstructured":"Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest. 2012;122(12):4654\u201366. https:\/\/doi.org\/10.1172\/JCI63375.","journal-title":"J Clin Invest"},{"issue":"3","key":"5604_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/ALN.0000000000000103","volume":"120","author":"S Kratzer","year":"2014","unstructured":"Kratzer S, Irl H, Mattusch C, et al. Tranexamic Acid Impairs \u03b3-Aminobutyric Acid Receptor Type A\u2013mediated Synaptic Transmission in the Murine Amygdala. Anesthesiology. 2014;120(3):639\u201349. https:\/\/doi.org\/10.1097\/ALN.0000000000000103.","journal-title":"Anesthesiology"},{"issue":"1","key":"5604_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1528-1157.1982.tb05051.x","volume":"23","author":"A Pellegrini","year":"1982","unstructured":"Pellegrini A, Giaretta D, Chemello R, Zanotto L, Testa G. Feline Generalized Epilepsy Induced by Tranexamic Acid (AMCA). Epilepsia. 1982;23(1):35\u201345. https:\/\/doi.org\/10.1111\/j.1528-1157.1982.tb05051.x.","journal-title":"Epilepsia"},{"issue":"1","key":"5604_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1213\/01.ane.0000250436.17786.72","volume":"104","author":"PS Garcha","year":"2007","unstructured":"Garcha PS, Mohan CVR, Sharma RM. Death After an Inadvertent Intrathecal Injection of Tranexamic Acid: Anesth Analg. 2007;104(1):241\u20132. https:\/\/doi.org\/10.1213\/01.ane.0000250436.17786.72.","journal-title":"Death After an Inadvertent Intrathecal Injection of Tranexamic Acid: Anesth Analg"},{"key":"5604_CR31","doi-asserted-by":"publisher","unstructured":"de Leede-van der Maarl MGJ, Hilkens P, Bosch F. The epileptogenic effect of tranexamic acid. J Neurol. 1999;246(9):843\u2013843. doi:https:\/\/doi.org\/10.1007\/s004150050466","DOI":"10.1007\/s004150050466"},{"issue":"1","key":"5604_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00000542-200301000-00042","volume":"98","author":"HM Yeh","year":"2003","unstructured":"Yeh HM, Lau HP, Lin PL, Sun WZ, Mok MS. Convulsions and Refractory Ventricular Fibrillation after Intrathecal Injection of a Massive Dose of Tranexamic Acid. Anesthesiology. 2003;98(1):270\u20132. https:\/\/doi.org\/10.1097\/00000542-200301000-00042.","journal-title":"Anesthesiology"},{"issue":"1","key":"5604_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12630-011-9618-z","volume":"59","author":"RA Manji","year":"2012","unstructured":"Manji RA, Grocott HP, Leake J, et al. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anesth Can Anesth. 2012;59(1):6\u201313. https:\/\/doi.org\/10.1007\/s12630-011-9618-z.","journal-title":"Can J Anesth Can Anesth"},{"issue":"1","key":"5604_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1053\/j.jvca.2010.10.007","volume":"25","author":"K Martin","year":"2011","unstructured":"Martin K, Knorr J, Breuer T, et al. Seizures After Open Heart Surgery: Comparison of \u03b5-Aminocaproic Acid and Tranexamic Acid. J Cardiothorac Vasc Anesth. 2011;25(1):20\u20135. https:\/\/doi.org\/10.1053\/j.jvca.2010.10.007.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"5604_CR35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1053\/j.jvca.2016.10.001","volume":"31","author":"T Maeda","year":"2017","unstructured":"Maeda T, Sasabuchi Y, Matsui H, Ohnishi Y, Miyata S, Yasunaga H. Safety of Tranexamic Acid in Pediatric Cardiac Surgery: A Nationwide Database Study. J Cardiothorac Vasc Anesth. 2017;31(2):549\u201353. https:\/\/doi.org\/10.1053\/j.jvca.2016.10.001.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"5604_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.24558","volume":"79","author":"I Lecker","year":"2016","unstructured":"Lecker I, Wang D, Whissell PD, Avramescu S, Mazer CD, Orser BA. Tranexamic acid\u2013associated seizures: Causes and treatment. Ann Neurol. 2016;79(1):18\u201326. https:\/\/doi.org\/10.1002\/ana.24558.","journal-title":"Ann Neurol"},{"issue":"6","key":"5604_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"R Deyo","year":"1992","unstructured":"Deyo R. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u20139. https:\/\/doi.org\/10.1016\/0895-4356(92)90133-8.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"5604_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00000539-200107000-00018","volume":"93","author":"DT Neilipovitz","year":"2001","unstructured":"Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg. 2001;93(1):82\u20137. https:\/\/doi.org\/10.1097\/00000539-200107000-00018.","journal-title":"Anesth Analg"},{"issue":"3","key":"5604_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/BPO.0b013e31819a85de","volume":"29","author":"JA Grant","year":"2009","unstructured":"Grant JA, Howard J, Luntley J, Harder J, Aleissa S, Parsons D. Perioperative blood transfusion requirements in pediatric scoliosis surgery: the efficacy of tranexamic acid. J Pediatr Orthop. 2009;29(3):300\u20134. https:\/\/doi.org\/10.1097\/BPO.0b013e31819a85de.","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"5604_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13013-015-0052-9","volume":"10","author":"BKW Ng","year":"2015","unstructured":"Ng BKW, Chau W, Hung ALH, Hui AC, Lam TP, Cheng JCY. Use of Tranexamic Acid (TXA) on reducing blood loss during scoliosis surgery in Chinese adolescents. Scoliosis. 2015;10(1):28. https:\/\/doi.org\/10.1186\/s13013-015-0052-9.","journal-title":"Scoliosis"},{"issue":"8","key":"5604_CR41","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1097\/BPO.0000000000000820","volume":"37","author":"DJ Johnson","year":"2017","unstructured":"Johnson DJ, Johnson CC, Goobie SM, et al. High-dose Versus Low-dose Tranexamic Acid to Reduce Transfusion Requirements in Pediatric Scoliosis Surgery. J Pediatr Orthop. 2017;37(8):e552\u20137. https:\/\/doi.org\/10.1097\/BPO.0000000000000820.","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"5604_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14444\/4027","volume":"11","author":"KE Jones","year":"2017","unstructured":"Jones KE, Butler EK, Barrack T, et al. Tranexamic Acid Reduced the Percent of Total Blood Volume Lost During Adolescent Idiopathic Scoliosis Surgery. Int J Spine Surg. 2017;11(4):27. https:\/\/doi.org\/10.14444\/4027.","journal-title":"Int J Spine Surg"},{"key":"5604_CR43","doi-asserted-by":"publisher","unstructured":"Ohashi N, Ohashi M, Endo N, Kohno T. Administration of tranexamic acid to patients undergoing surgery for adolescent idiopathic scoliosis evokes pain and increases the infusion rate of remifentanil during the surgery. Sumitani M, ed. PLOS ONE. 2017;12(3):e0173622. doi:https:\/\/doi.org\/10.1371\/journal.pone.0173622","DOI":"10.1371\/journal.pone.0173622"},{"key":"5604_CR44","doi-asserted-by":"publisher","unstructured":"Yang B, Li H, Wang D, He X, Zhang C, Yang P. Systematic Review and Meta-Analysis of Perioperative Intravenous Tranexamic Acid Use in Spinal Surgery. Landoni G, ed. PLoS ONE. 2013;8(2):e55436. doi:https:\/\/doi.org\/10.1371\/journal.pone.0055436","DOI":"10.1371\/journal.pone.0055436"},{"issue":"14","key":"5604_CR45","doi-asserted-by":"publisher","first-page":"E879","DOI":"10.1097\/BRS.0000000000001454","volume":"41","author":"A Soroceanu","year":"2016","unstructured":"Soroceanu A, Oren JH, Smith JS, et al. Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery. Spine. 2016;41(14):E879\u201386. https:\/\/doi.org\/10.1097\/BRS.0000000000001454.","journal-title":"Spine"},{"issue":"1","key":"5604_CR46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12891-022-05361-2","volume":"23","author":"T Lei","year":"2022","unstructured":"Lei T, Bingtao W, Zhaoqing G, Zhongqiang C, Xin L. The efficacy and safety of intravenous tranexamic acid in patients with posterior operation of multilevel thoracic spine stenosis: a prospective randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):410. https:\/\/doi.org\/10.1186\/s12891-022-05361-2.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"5604_CR47","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1097\/BSD.0000000000000860","volume":"33","author":"BS Ko","year":"2020","unstructured":"Ko BS, Cho KJ, Kim YT, Park JW, Kim NC. Does Tranexamic Acid Increase the Incidence of Thromboembolism After Spinal Fusion Surgery? Clin Spine Surg Spine Publ. 2020;33(2):E71\u20135. https:\/\/doi.org\/10.1097\/BSD.0000000000000860.","journal-title":"Clin Spine Surg Spine Publ"},{"issue":"1","key":"5604_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/JTN.0000000000000553","volume":"28","author":"B Cornelius","year":"2021","unstructured":"Cornelius B, Cummings Q, Assercq M, Rizzo E, Gennuso S, Cornelius A. Current Practices in Tranexamic Acid Administration for Pediatric Trauma Patients in the United States. J Trauma Nurs. 2021;28(1):21\u20135. https:\/\/doi.org\/10.1097\/JTN.0000000000000553.","journal-title":"J Trauma Nurs"},{"issue":"6","key":"5604_CR49","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/TA.0000000000000443","volume":"77","author":"MJ Eckert","year":"2014","unstructured":"Eckert MJ, Wertin TM, Tyner SD, Nelson DW, Izenberg S, Martin MJ. Tranexamic acid administration to pediatric trauma patients in a combat setting: The pediatric trauma and tranexamic acid study (PED-TRAX). J Trauma Acute Care Surg. 2014;77(6):852\u20138. https:\/\/doi.org\/10.1097\/TA.0000000000000443.","journal-title":"J Trauma Acute Care Surg"},{"key":"5604_CR50","doi-asserted-by":"publisher","unstructured":"Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10). doi:https:\/\/doi.org\/10.3310\/hta17100","DOI":"10.3310\/hta17100"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-022-05604-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T04:02:56Z","timestamp":1657252976000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-022-05604-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5604"],"URL":"https:\/\/doi.org\/10.1186\/s12891-022-05604-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted and reported in accordance with the Declaration of Helsinki. The institutional review board and ethical committee at Weill Cornell Medicine gave approval to conduct this study with a waiver of informed consent due to the deidentified nature of the data source.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ms. Ivasyk has no disclosures, Mr. Chatterjee has no disclosures, Ms. Jordan has no disclosures, Mr. Geiselmann has no disclosures, Dr. Chang has no disclosures, Dr. Kamel serves as a PI for the NIH-funded ARCADIA trial (NINDS U01NS095869) which receives in-kind study drug from the BMS-Pfizer Alliance for Eliquis\u00ae and ancillary study support from Roche Diagnostics, serves as Deputy Editor for JAMA Neurology, serves as a steering committee member of Medtronic\u2019s Stroke AF trial (uncompensated), and serves on an endpoint adjudication committee for a trial of empagliflozin for Boehringer-Ingelheim, Dr. Khormaee has no disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"651"}}